TCL Archive FDA Approves Tamoxifen For “Reduction In Incidence,” Avoids Word “Prevention” November 6, 1998
TCL Archive Perjeta Neoadjuvant Therapy Granted Accelerated Approval In HER2 Breast Cancer October 25, 2013
TCL Archive NCI advisors approve recompetition of $62 million phase II contracts program. November 19, 2004